OIE Reference Laboratory Reports Activities

Transcription

1 OIE Reference Laboratory Reports Activities Activities in 2013 This report has been submitted : :45:52 Name of disease (or topic) for which you are a designated OIE Reference Laboratory: Bovine tuberculosis Address of laboratory: New Haw, Addlestone Surrey KT15 3NB Weybridge UNITED KINGDOM Tel.: Fax: address: glyn.hewinson@ahvla.gsi.gov.uk website: Name (including Title) of Head of Laboratory (Responsible Official): Mr Chris Hadkiss, CEO Name (including Title and Position) of OIE Reference Expert: Prof Glyn Hewinson, Chief Scientist Which of the following defines your laboratory? Check all that apply: Governmental OIE Reference Laboratory Reports Activities,

2 ToR: To use, promote and disseminate diagnostic methods validated according to OIE Standards 1. Did your laboratory perform diagnostic tests for the specified disease/topic for purposes such as disease diagnosis, screening of animals for export, surveillance, etc.? (t for quality control, proficiency testing or staff training) Diagnostic Test Indicated in OIE Manual (/) Total number of test performed last year Indirect diagnostic tests Nationally Internationally Lateral flow serology test - camelid Lateral flow serology test - badger Lateral flow serology test - bovine 41 0 Lateral flow serology test - other 44 1 Gamma interferon micro (2Ag) assay (cattle) Direct diagnostic tests Nationally Internationally Culture (bovine) Culture (non bovine) HAIN & Multiplex PCRs 13 0 DNA testing of cattle to confirm identity tallies with ear tag Spoligotyping - bovine ToR: To develop reference material in accordance with OIE requirements, and implement and promote the application of OIE Standards. To store and distribute to national laboratories biological reference products and any other reagents used in the diagnosis and control of the designated pathogens or disease. 2. Did your laboratory produce or supply imported standard reference reagents officially recognised by the OIE? 2 OIE Reference Laboratory Reports Activities, 2013

3 3. Did your laboratory supply standard reference reagents (non OIE-approved) and/or other diagnostic reagents to OIE Member Countries? Type of reagent available Related diagnostic test Produced/ provide Amount supplied nationally (ml, mg) Amount supplied internationally (ml, mg). of recipient OIE Member Countries Region of recipients Africa DIVA antigens (synthetic peptide and recombinant proteins) skin testing and Gamma-interferon assay provide 1 mg 13 mg Americas Asia and Pacific Europe Middle East 4. Did your laboratory produce vaccines? 5. Did your laboratory supply vaccines to OIE Member Countries? ToR: To develop, standardise and validate, according to OIE Standards, new procedures for diagnosis and control of the designated pathogens or diseases 6. Did your laboratory develop new diagnostic methods validated according to OIE Standards for the designated pathogen or disease? 7. Did your laboratory develop new vaccines according to OIE Standards for the designated pathogen or disease? ToR: To provide diagnostic testing facilities, and, where appropriate, scientific and technical advice on disease control measures to OIE Member Countries 8. Did your laboratory carry out diagnostic testing for other OIE Member Countries? OIE Reference Laboratory Reports Activities,

4 Name of OIE Member Country seeking assistance Date (month). samples received for provision of diagnostic support. samples received for provision of confirmatory diagnoses SWEDEN IRELAND Did your laboratory provide expert advice in technical consultancies on the request of an OIE Member Country? ToR: To carry out and/or coordinate scientific and technical studies in collaboration with other laboratories, centres or organisations 10. Did your laboratory participate in international scientific studies in collaboration with OIE Member Countries other than the own? Title of the study Duration Purpose of the study Partners (Institutions) European 2 a clonal complex of Mycobacterium bovis dominant in the Iberian Peninsula. 1 year To determine the population structure of M. bovis in the Iberian Peninsula European Union Reference Laboratory (EURL) The effect of repeat BCG vaccination on the specificity of a blood based DIVA test 6 months To determine if repeat BCG vaccination effects the specificity of a blood based DIVA test European Union Reference Laboratory (EURL) EFSA: Scientific Opinion on the use of the IFN-gamma test for the diagnosis of BTB ~ 4 months To assess the suitability of the IFNgamma test as a stand-alone test for gaining, maintaining, suspending, withdrawing or regaining official BTBfree status AHVLA (UK), CVI Lelystad, UCD, Ag. Academy, Lublin, Fed. Res. Inst. For An. Health, Madrid TB Ref. Lab, Fed. Vet. Office, National TB Ref. Lab., IZSLER, Vet. Agro. Research Centre. Evaluation of oral vaccine efficacy in badgers Ongoing To evaluate vaccine efficacy in a low dose challenge model UCD Field evaluation of BCG vaccination in cattle ongoing See study title Armauer Hansen Research Institute and Addis Ababa University Validation of DIVA peptide antigen stability ongoing See study title Prionics Assessment of M tuberculosis virulence in cattle ongoing See study title INRA (France), UCD (Ireland), Armauer Hansen Research Institute Ethiopia Evaluation of DIVA antigens and tests using different experimental TB vaccines ongoing See study title European Union Reference Laboratory (EURL) Evaluation of DIVA skin test reagents in cattle ongoing To evaluate the performance of DIVA skin test reagents in cattle AgResearch New Zealand Mel-Vac 2 15 months Test protective efficacy of an oral heat-inactivated M.bovis vaccine in badgers Anses, IREC, Neilker, UCD, 4 OIE Reference Laboratory Reports Activities, 2013

5 ToR: To collect, process, analyse, publish and disseminate epizootiological data relevant to the designated pathogens or diseases 11. Did your Laboratory collect epizootiological data relevant to international disease control? 12. Did your laboratory disseminate epizootiological data that had been processed and analysed? 13. What method of dissemination of information is most often used by your laboratory? (Indicate in the appropriate box the number by category) a) Articles published in peer-reviewed journals: Khatri B; Fielder M; Jones G; Newell W; Abu-Oun M; Wheeler PR. High throughput phenotypic analysis of Mycobacterium tuberculosis and Mycobacterium bovis strains' metabolism using Biolog Phenotype Microarrays. PLoS ONE 2013; 8(1): e Van Der Burgt GM; Drummond F; Crawshaw T; Morris S. An outbreak of tuberculosis in Lleyn sheep in the UK associated with clinical signs. Veterinary Record 2013; 172(3): Downs SH; Clifton-Hadley RS; Upton PA; Milne I; Ely ER; Gopal R; Goodchild AV; Sayers AR. Tuberculin manufacturing source and breakdown incidence rate of bovine tuberculosis in British cattle, Veterinary Record 2013; 172(4): Brown E; Cooney R; Rogers F. Veterinary guidance on the practical use of the BadgerBCG tuberculosis vaccine. In Practice 2013; 35(3) : Coad M; Clifford DJ; Vordermeier HM; Whelan AO. Consequences of vaccination with the Johne's disease vaccine, Gudair, for diagnosis of bovine tuberculosis. Veterinary Record 2013; 172(10): Amos W; Brooks-Pollock E; Blackwell R; Driscoll E; Nelson-Flower M; Conlan AJK. Genetic predisposition to pass the standard SICCT test for bovine tuberculosis in British cattle. PLoS ONE (3): e Firdessa R; Berg S; Hailu E; Schelling E; Gumi B; Erenso G; Gadisa E; Kiros T; Habtamu M; Hussein J; Zinsstag J; Robertson BD; Ameni G; Lohan AJ; Loftus B; Comas I; Gagneaux S; Tschopp R; Yamuah L; Hewinson G; Gordon SV; Young DB; Aseffa A. Mycobacterial lineages causing pulmonary and extrapulmonary tuberculosis, Ethiopia. Emerging Infectious Diseases 2013; 19(3): Awah-Ndukum J; Kudi AC; Bradley G; Smith NH; Ane-Anyangwe I; Cho-Ngwa F; Titanji VPK. Molecular genotyping of Mycobacterium bovis isolated from cattle tissues in the rth West Region of Cameroon. Tropical Animal Health and Production 2013; 45(3): Abernethy DA; Upton P; Higgins IM; McGrath G; Goodchild AV; Rolfe SJ; Broughan JM; Downs SH; Clifton-Hadley R; Menzies FD; De La Rua-Domenech R; Blissitt MJ; Duignan A; More SJ. Bovine tuberculosis trends in the United Kingdom and Republic of Ireland, Veterinary Record 2013; 172(12): Schoning JM; Cerny N; Prohaska S; Wittenbrink MM; Smith NH; Bloemberg G; Pewsner M; Schiller I; Origgi FC; Ryser-Degiorgis MP. Surveillance of bovine tuberculosis and risk estimation of a future reservoir formation in wildlife in Switzerland and Liechtenstein. PLoS ONE 2013; 8(1): e Garcia-Jimenez WL; Benitez-Medina JM; Fernandez-Llario P; Abecia JA; Garcia-Sanchez A; Martinez R; Risco D; Ortiz-Pelaez A; Salguero FJ; Smith NH; Gomez L; Hermoso de Mendoza J. Comparative pathology of the natural infections by Mycobacterium bovis and by Mycobacterium caprae in Wild Boar (Sus scrofa). Transboundary and Emerging Diseases 2013; 60(2): García-Jimenez WL; Fernandez-Llario P; Benitez-Medina JM; Cerrato R; Cuesta J; Garcia-Sanchez A; Goncalves P; Martinez R; Risco D; Salguero FJ; Serrano E; Gomez L; Hermoso-de-Mendoza J. Reducing Eurasian wild boar (Sus scrofa) population density as a measure for bovine tuberculosis control: Effects in wild boar and a sympatric fallow deer (Dama dama) population in Central Spain. Preventive Veterinary Medicine 2013; 110(3 4): Jones RM; Ashford R; Cork J; Palmer S; Wood E; Spyvee P; Parks S; Bennett A; Brewer J; Delahay R; Chambers M; Sawyer J. Evaluation of a method to detect Mycobacterium bovis in air samples from infected Eurasian badgers (Meles meles) and their setts. Letters in Applied Microbiology 2013; 56(5): Shittu A; Clifton-Hadley RS; Ely ER; Upton PU; Downs SH. Factors associated with bovine tuberculosis confirmation rates in suspect lesions found in cattle at routine slaughter in Great Britain, Preventive Veterinary Medicine 2013; 110(3 4): Tomlinson AJ; Chambers MA; Carter SP; Wilson GJ; Smith GC; McDonald RA; Delahay RJ. Heterogeneity in the risk of Mycobacterium bovis infection in European badger (Meles meles) cubs. Epidemiology and Infection 2013; 141(7): OIE Reference Laboratory Reports Activities,

6 16. Delahay RJ; Walker N; Smith GS; Wilkinson ; Clifton-Hadley RS; Cheeseman CL; Tomlinson AJ; Chambers MA. Long-term temporal trends and estimated transmission rates for Mycobacterium bovis infection in an undisturbed high-density badger (Meles meles) population. Epidemiology and Infection 2013; 141(7): Barnett JEF; Booth P; Brewer JI; Davison NJ; Greenwood A; Riley P; Smith NH; Wessels M. Mycobacterium bovis infection in a grey seal pup (Halichoerus grypus). Veterinary Record 2013; 173(7): Buddle BM; Hewinson RG; Vordermeier HM; Wedlock DN. Subcutaneous administration of a 10-fold-lower dose of a commercial human tuberculosis vaccine, Mycobacterium bovis Bacillus Calmette-Guérin Danish, induced levels of protection against bovine tuberculosis and responses in the tuberculin intradermal test similar to those induced by a standard cattle dose. Clinical and Vaccine Immunology 2013; 20(10): Crawshaw T; Rua-Domenech RDL; Brown E. Recognising the gross pathology of tuberculosis in South American camelids, deer, goats, pigs and sheep. In Practice 2013; 35(9): Aranday-Cortes E; Bull NC; Villarreal-Ramos B; Gough J; Hicks D; Ortiz-Pelaez A; Vordermeier HM; Salguero FJ. Upregulation of IL-17A, CXCL9 and CXCL10 in early-stage granulomas induced by Mycobacterium bovis in cattle. Transboundary and Emerging Diseases 2013; 60(6): Ameni G; Tadesse K; Hailu E; Deresse Y; Medhin G; Aseffa A; Hewinson G; Vordermeier M; Berg S. Transmission of Mycobacterium tuberculosis between farmers and cattle in Central Ethiopia. PLoS ONE 2013; 8(10): e Van Der Burgt GM; Drummond F; Crawshaw T; Morris S. An outbreak of tuberculosis in Lleyn sheep in the UK associated with clinical signs. Veterinary Record 2013; 172(3): Rodriguez-Campos S; Navarro Y; Romero B; de Juan L; Bezos J; Mateos A; Golby P; Smith NH; Hewinson GR; Dominguez L; Garcia-de-Viedma D; Aranaz A. Splitting of a prevalent Mycobacterium bovis spoligotype by variable-number tandem-repeat typing reveals high heterogeneity in an evolving clonal group. Journal of Clinical Microbiology 2013; 51(11): Jones GJ; Khatri BL; Garcia-Pelayo MC; Kaveh DA; Bachy VS; Hogarth PJ; Wooff E; Golby P; Vordermeier HM. Development of an unbiased antigen-mining approach to identify novel vaccine antigens and diagnostic reagents for bovine tuberculosis. Clinical and Vaccine Immunology 2013; 20(11): Brooks-Pollock E; Conlan A; Mitchell A; Blackwell R; McKinley T; Wood J. Age-dependent patterns of bovine tuberculosis in cattle. Veterinary Research 2013; 44(1): Garcia-Jimenez WL; Salguero FJ; Fernandez-Llario P; Martinez R; Risco D; Gough J; Ortiz-Pelaez A; Hermoso-d- -Mendoza J; Gomes L. Immunopathology of granulomas produced by Mycobacterium bovis in naturally infected wild boar. Veterinary Immunology and Immunopathology 2013; 156(1-2): Perez de Val B; Vidal E; Villarreal-Ramos B; Gilbert SC; Andaluz A; Moll X; Martin M; frarias M; McShane H; Vordermeier HM; Domingo M. A multi-antigenic adenoviral-vectored vaccine improves BCG-induced protection of goats against pulmonary tuberculosis infection and prevents disease progression. PLoS ONE 2013; 8(11): e Chambers MA. Review of the diagnosis of tuberculosis in non-bovid wildlife species using immunological methods - an update of published work since Transboundary and Emerging Diseases 2013; 60(Suppl. S1): Tomlinson AJ; Chambers MA; Wilson GJ; McDonald RA; Delahay RJ. Sex-related heterogeneity in the life-history correlates of Mycobacterium bovis infection in European badgers (Meles meles). Transboundary and Emerging Diseases; 60(Suppl. 1): Weber N; Carter SR; Dall SRX; Delahay RJ; McDonald JL; Bearhop S; McDonald RA. Badger social networks correlate with tuberculosis infection. Current Biology 2013; 23(20): R915-R Allen AR; Dale J; McCormick C; Mallon TR; Costello E; Gordon SV; Hewinson RG; Skuce RA; Smith NH. The phylogeny and population structure of Mycobacterium bovis in the British Isles. Infection, Genetics and Evolution 2013; 20: Broughan JM; Downs SH; Crawshaw TR; Upton PA; Clifton-Hadley RS. Mycobacterium bovis infections in domesticated non-bovine mammalian species. Part 1: Review of epidemiology and laboratory submissions in Great Britain Veterinary Journal 2013; 198(2): Broughan JM; Crawshaw TR; Downs SH; Brewer J; Clifton-Hadley RS. Mycobacterium bovis infections in domesticated non-bovine mammalian species. Part 2: A review of diagnostic methods. Veterinary Journal 2013; 198(2): Bailey SS; Crawshaw TR; Smith NH; Palgrave CJ. Mycobacterium bovis infection in domestic pigs in Great Britain. Veterinary Journal 2013; 198(2): b) International conferences: 3 International Veterinary Immunology Symposium in Milan Annual German Symposium on Bovine Tuberculosis in Jena Belgium wildlife Disease Association Meeting c) National conferences: 2 Zoological Society of London Special event on bovine tuberculosis, London AHVLA Veterinary Conference 6 OIE Reference Laboratory Reports Activities, 2013

7 d) Other: (Provide website address or link to appropriate information) 0 ToR: To provide scientific and technical training for personnel from OIE Member Countries To recommend the prescribed and alternative tests or vaccines as OIE Standards 14. Did your laboratory provide scientific and technical training to laboratory personnel from other OIE Member Countries? a) Technical visits: 3 b) Seminars: 0 c) Hands-on training courses: 1 d) Internships (>1 month): 1 Type of technical training provided (a, b, c or d) Country of origin of the expert(s) provided with training. participants from the corresponding country a Korea 1 a, c Ethiopia 2 a France 1 ToR: To maintain a system of quality assurance, biosafety and biosecurity relevant for the pathogen and the disease concerned 15. Does your laboratory have a Quality Management System certified according to an International Standard? Quality management system adopted ISO 17025; ISO 9001;Good Distribution Practice (GDP) 94/C63/03;Good Laboratory Practice (GLP) 16. Is your laboratory accredited by an international accreditation body? OIE Reference Laboratory Reports Activities,

8 Test for which your laboratory is accredited Culture (bovine & non bovine) Gamma Interferon Elisa Culture (bovine & non bovine) Spoligotyping Accreditation body UKAS UKAS GLP UKAS 17. Does your laboratory maintain a biorisk management system for the pathogen and the disease concerned? (See Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 2012, Chapter or Manual of Diagnostic Tests for Aquatic Animals 2012, Chapter 1.1.1) ToR: To organise and participate in scientific meetings on behalf of the OIE 18. Did your laboratory organise scientific meetings on behalf of the OIE? 19. Did your laboratory participate in scientific meetings on behalf of the OIE? ToR: To establish and maintain a network with other OIE Reference Laboratories designated for the same pathogen or disease and organise regular inter-laboratory proficiency testing to ensure comparability of results 20. Did your laboratory exchange information with other OIE Reference Laboratories designated for the same pathogen or disease? 21. Was your laboratory involved in maintaining a network with OIE Reference Laboratories designated for the same pathogen or disease by organising or participating in proficiency tests? 22. Did your laboratory collaborate with other OIE Reference Laboratories for the same disease on scientific research projects for the diagnosis or control of the pathogen of interest? 8 OIE Reference Laboratory Reports Activities, 2013

9 ToR: To organise inter-laboratory proficiency testing with laboratories other than OIE Reference Laboratories for the same pathogens and diseases to ensure equivalence of results 23. Did your laboratory organise or participate in inter-laboratory proficiency tests with laboratories other than OIE Reference Laboratories for the same disease? te: See Interlaboratory test comparisons in: Laboratory Proficiency Testing at: see point 1.3 Purpose for inter-laboratory test comparisons 1. participating laboratories Region(s) of participating OIE Member Countries EU RL organised proficiency test: Comparative test for the detection of interferon gamma for the diagnosis of bovine tuberculosis 11 Africa Americas Asia and Pacific Europe Middle East EU RL organised proficiency test: Mycobacteria recovery from different culture media 19 Africa Americas Asia and Pacific Europe Middle East EU RL organised proficiency test: Analytical sensitivity of PCR 15 Africa Americas Asia and Pacific Europe Middle East EU RL organised proficiency test: Comparative test for bacteriological culture and direct diagnosis of tuberculosis (by PCR) from clinical tissue samples information not supplied or available Africa Americas Asia and Pacific Europe Middle East ToR: To place expert consultants at the disposal of the OIE 24. Did your laboratory place expert consultants at the disposal of the OIE? Kind of consultancy Location Subject (facultative) Member of Biological Standards Commission Responding to requests for consultancy on test validation Paris and AHVLA Attendance at BSC meetings, comments on papers etc Responding to requests for consultancy on test validation AHVLA Test validation OIE Reference Laboratory Reports Activities,

10 25. Additional comments regarding your report: Bovine tuberculosis - Glyn Hewinson - united kingdom Unable to add all diagnostic testing carried out because of lack of rows in table (Section 1). Additional testing information: Indirect diagnostic tests: Test:Gamma interferon extended micro (3Ag) assay (cattle); Numbers tested nationally:149; Numbers tested internationally: 146. Direct diagnostic tests: Test: Spoligotyping non bovine; Numbers tested nationally:299; Numbers tested internationally: 0. Test: VNTR bovine; Numbers tested nationally:4647; Numbers tested internationally: 1. Test: VNTR non bovine; Numbers tested nationally:147; Numbers tested internationally: OIE Reference Laboratory Reports Activities, 2013